Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study

Substantial reductions in adult mortality have been observed in South Africa since the mid-2000s, but there has been no formal evaluation of how much of this decline is attributable to the scale-up of antiretroviral treatment (ART), as previous models have not been calibrated to vital registration d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PLoS medicine Jg. 14; H. 12; S. e1002468
Hauptverfasser:	Johnson, Leigh F., May, Margaret T., Dorrington, Rob E., Cornell, Morna, Boulle, Andrew, Egger, Matthias, Davies, Mary-Ann
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Public Library of Science 12.12.2017 Public Library of Science (PLoS)
Schlagworte:	Acquired immune deficiency syndrome Adult Adults AIDS Antiretroviral agents Antiretroviral drugs Antiretroviral therapy Antiretroviral Therapy, Highly Active - methods Bayes Theorem Bayesian analysis Biology and Life Sciences Computer simulation Death Drug therapy Epidemics Epidemiology Fatalities Female Health care Highly active antiretroviral therapy HIV HIV Infections - drug therapy HIV Infections - mortality HIV Infections - transmission Human immunodeficiency virus Humans Infectious diseases Life expectancy Male Mathematical models Medicine and Health Sciences Middle Aged Models, Theoretical Mortality Mortality - trends Patient outcomes People and places Population Preventive medicine Registration South Africa - epidemiology Studies Trends Tuberculosis Young Adult South Africa
ISSN:	1549-1676, 1549-1277, 1549-1676
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	Substantial reductions in adult mortality have been observed in South Africa since the mid-2000s, but there has been no formal evaluation of how much of this decline is attributable to the scale-up of antiretroviral treatment (ART), as previous models have not been calibrated to vital registration data. We developed a deterministic mathematical model to simulate the mortality trends that would have been expected in the absence of ART, and with earlier introduction of ART. Model estimates of mortality rates in ART patients were obtained from the International Epidemiology Databases to Evaluate AIDS-Southern Africa (IeDEA-SA) collaboration. The model was calibrated to HIV prevalence data (1997-2013) and mortality data from the South African vital registration system (1997-2014), using a Bayesian approach. In the 1985-2014 period, 2.70 million adult HIV-related deaths occurred in South Africa. Adult HIV deaths peaked at 231,000 per annum in 2006 and declined to 95,000 in 2014, a reduction of 74.7% (95% CI: 73.3%-76.1%) compared to the scenario without ART. However, HIV mortality in 2014 was estimated to be 69% (95% CI: 46%-97%) higher in 2014 (161,000) if the model was calibrated only to HIV prevalence data. In the 2000-2014 period, the South African ART programme is estimated to have reduced the cumulative number of HIV deaths in adults by 1.72 million (95% CI: 1.58 million-1.84 million) and to have saved 6.15 million life years in adults (95% CI: 5.52 million-6.69 million). This compares with a potential saving of 8.80 million (95% CI: 7.90 million-9.59 million) life years that might have been achieved if South Africa had moved swiftly to implement WHO guidelines (2004-2013) and had achieved high levels of ART uptake in HIV-diagnosed individuals from 2004 onwards. The model is limited by its reliance on all-cause mortality data, given the lack of reliable cause-of-death reporting, and also does not allow for changes over time in tuberculosis control programmes and ART effectiveness. ART has had a dramatic impact on adult mortality in South Africa, but delays in the rollout of ART, especially in the early stages of the ART programme, have contributed to substantial loss of life. This is the first study to our knowledge to calibrate a model of ART impact to population-level recorded death data in Africa; models that are not calibrated to population-level death data may overestimate HIV-related mortality.
AbstractList	Substantial reductions in adult mortality have been observed in South Africa since the mid-2000s, but there has been no formal evaluation of how much of this decline is attributable to the scale-up of antiretroviral treatment (ART), as previous models have not been calibrated to vital registration data. We developed a deterministic mathematical model to simulate the mortality trends that would have been expected in the absence of ART, and with earlier introduction of ART. Model estimates of mortality rates in ART patients were obtained from the International Epidemiology Databases to Evaluate AIDS-Southern Africa (IeDEA-SA) collaboration. The model was calibrated to HIV prevalence data (1997-2013) and mortality data from the South African vital registration system (1997-2014), using a Bayesian approach. In the 1985-2014 period, 2.70 million adult HIV-related deaths occurred in South Africa. Adult HIV deaths peaked at 231,000 per annum in 2006 and declined to 95,000 in 2014, a reduction of 74.7% (95% CI: 73.3%-76.1%) compared to the scenario without ART. However, HIV mortality in 2014 was estimated to be 69% (95% CI: 46%-97%) higher in 2014 (161,000) if the model was calibrated only to HIV prevalence data. In the 2000-2014 period, the South African ART programme is estimated to have reduced the cumulative number of HIV deaths in adults by 1.72 million (95% CI: 1.58 million-1.84 million) and to have saved 6.15 million life years in adults (95% CI: 5.52 million-6.69 million). This compares with a potential saving of 8.80 million (95% CI: 7.90 million-9.59 million) life years that might have been achieved if South Africa had moved swiftly to implement WHO guidelines (2004-2013) and had achieved high levels of ART uptake in HIV-diagnosed individuals from 2004 onwards. The model is limited by its reliance on all-cause mortality data, given the lack of reliable cause-of-death reporting, and also does not allow for changes over time in tuberculosis control programmes and ART effectiveness. ART has had a dramatic impact on adult mortality in South Africa, but delays in the rollout of ART, especially in the early stages of the ART programme, have contributed to substantial loss of life. This is the first study to our knowledge to calibrate a model of ART impact to population-level recorded death data in Africa; models that are not calibrated to population-level death data may overestimate HIV-related mortality. Background Substantial reductions in adult mortality have been observed in South Africa since the mid-2000s, but there has been no formal evaluation of how much of this decline is attributable to the scale-up of antiretroviral treatment (ART), as previous models have not been calibrated to vital registration data. We developed a deterministic mathematical model to simulate the mortality trends that would have been expected in the absence of ART, and with earlier introduction of ART. Methods and findings Model estimates of mortality rates in ART patients were obtained from the International Epidemiology Databases to Evaluate AIDS-Southern Africa (IeDEA-SA) collaboration. The model was calibrated to HIV prevalence data (1997-2013) and mortality data from the South African vital registration system (1997-2014), using a Bayesian approach. In the 1985-2014 period, 2.70 million adult HIV-related deaths occurred in South Africa. Adult HIV deaths peaked at 231,000 per annum in 2006 and declined to 95,000 in 2014, a reduction of 74.7% (95% CI: 73.3%-76.1%) compared to the scenario without ART. However, HIV mortality in 2014 was estimated to be 69% (95% CI: 46%-97%) higher in 2014 (161,000) if the model was calibrated only to HIV prevalence data. In the 2000-2014 period, the South African ART programme is estimated to have reduced the cumulative number of HIV deaths in adults by 1.72 million (95% CI: 1.58 million-1.84 million) and to have saved 6.15 million life years in adults (95% CI: 5.52 million-6.69 million). This compares with a potential saving of 8.80 million (95% CI: 7.90 million-9.59 million) life years that might have been achieved if South Africa had moved swiftly to implement WHO guidelines (2004-2013) and had achieved high levels of ART uptake in HIV-diagnosed individuals from 2004 onwards. The model is limited by its reliance on all-cause mortality data, given the lack of reliable cause-of-death reporting, and also does not allow for changes over time in tuberculosis control programmes and ART effectiveness. Conclusions ART has had a dramatic impact on adult mortality in South Africa, but delays in the rollout of ART, especially in the early stages of the ART programme, have contributed to substantial loss of life. This is the first study to our knowledge to calibrate a model of ART impact to population-level recorded death data in Africa; models that are not calibrated to population-level death data may overestimate HIV-related mortality. BackgroundSubstantial reductions in adult mortality have been observed in South Africa since the mid-2000s, but there has been no formal evaluation of how much of this decline is attributable to the scale-up of antiretroviral treatment (ART), as previous models have not been calibrated to vital registration data. We developed a deterministic mathematical model to simulate the mortality trends that would have been expected in the absence of ART, and with earlier introduction of ART.Methods and findingsModel estimates of mortality rates in ART patients were obtained from the International Epidemiology Databases to Evaluate AIDS-Southern Africa (IeDEA-SA) collaboration. The model was calibrated to HIV prevalence data (1997-2013) and mortality data from the South African vital registration system (1997-2014), using a Bayesian approach. In the 1985-2014 period, 2.70 million adult HIV-related deaths occurred in South Africa. Adult HIV deaths peaked at 231,000 per annum in 2006 and declined to 95,000 in 2014, a reduction of 74.7% (95% CI: 73.3%-76.1%) compared to the scenario without ART. However, HIV mortality in 2014 was estimated to be 69% (95% CI: 46%-97%) higher in 2014 (161,000) if the model was calibrated only to HIV prevalence data. In the 2000-2014 period, the South African ART programme is estimated to have reduced the cumulative number of HIV deaths in adults by 1.72 million (95% CI: 1.58 million-1.84 million) and to have saved 6.15 million life years in adults (95% CI: 5.52 million-6.69 million). This compares with a potential saving of 8.80 million (95% CI: 7.90 million-9.59 million) life years that might have been achieved if South Africa had moved swiftly to implement WHO guidelines (2004-2013) and had achieved high levels of ART uptake in HIV-diagnosed individuals from 2004 onwards. The model is limited by its reliance on all-cause mortality data, given the lack of reliable cause-of-death reporting, and also does not allow for changes over time in tuberculosis control programmes and ART effectiveness.ConclusionsART has had a dramatic impact on adult mortality in South Africa, but delays in the rollout of ART, especially in the early stages of the ART programme, have contributed to substantial loss of life. This is the first study to our knowledge to calibrate a model of ART impact to population-level recorded death data in Africa; models that are not calibrated to population-level death data may overestimate HIV-related mortality. Background Substantial reductions in adult mortality have been observed in South Africa since the mid-2000s, but there has been no formal evaluation of how much of this decline is attributable to the scale-up of antiretroviral treatment (ART), as previous models have not been calibrated to vital registration data. We developed a deterministic mathematical model to simulate the mortality trends that would have been expected in the absence of ART, and with earlier introduction of ART. Methods and findings Model estimates of mortality rates in ART patients were obtained from the International Epidemiology Databases to Evaluate AIDS-Southern Africa (IeDEA-SA) collaboration. The model was calibrated to HIV prevalence data (1997-2013) and mortality data from the South African vital registration system (1997-2014), using a Bayesian approach. In the 1985-2014 period, 2.70 million adult HIV-related deaths occurred in South Africa. Adult HIV deaths peaked at 231,000 per annum in 2006 and declined to 95,000 in 2014, a reduction of 74.7% (95% CI: 73.3%-76.1%) compared to the scenario without ART. However, HIV mortality in 2014 was estimated to be 69% (95% CI: 46%-97%) higher in 2014 (161,000) if the model was calibrated only to HIV prevalence data. In the 2000-2014 period, the South African ART programme is estimated to have reduced the cumulative number of HIV deaths in adults by 1.72 million (95% CI: 1.58 million-1.84 million) and to have saved 6.15 million life years in adults (95% CI: 5.52 million-6.69 million). This compares with a potential saving of 8.80 million (95% CI: 7.90 million-9.59 million) life years that might have been achieved if South Africa had moved swiftly to implement WHO guidelines (2004-2013) and had achieved high levels of ART uptake in HIV-diagnosed individuals from 2004 onwards. The model is limited by its reliance on all-cause mortality data, given the lack of reliable cause-of-death reporting, and also does not allow for changes over time in tuberculosis control programmes and ART effectiveness. Conclusions ART has had a dramatic impact on adult mortality in South Africa, but delays in the rollout of ART, especially in the early stages of the ART programme, have contributed to substantial loss of life. This is the first study to our knowledge to calibrate a model of ART impact to population-level recorded death data in Africa; models that are not calibrated to population-level death data may overestimate HIV-related mortality. Leigh Johnson and colleagues model the HIV epidemic in South Africa, using national level health statistics as inputs, to estimate the number of deaths avoided and extra years of life gained due to antiretroviral programs. Substantial reductions in adult mortality have been observed in South Africa since the mid-2000s, but there has been no formal evaluation of how much of this decline is attributable to the scale-up of antiretroviral treatment (ART), as previous models have not been calibrated to vital registration data. We developed a deterministic mathematical model to simulate the mortality trends that would have been expected in the absence of ART, and with earlier introduction of ART. Model estimates of mortality rates in ART patients were obtained from the International Epidemiology Databases to Evaluate AIDS-Southern Africa (IeDEA-SA) collaboration. The model was calibrated to HIV prevalence data (1997-2013) and mortality data from the South African vital registration system (1997-2014), using a Bayesian approach. In the 1985-2014 period, 2.70 million adult HIV-related deaths occurred in South Africa. Adult HIV deaths peaked at 231,000 per annum in 2006 and declined to 95,000 in 2014, a reduction of 74.7% (95% CI: 73.3%-76.1%) compared to the scenario without ART. However, HIV mortality in 2014 was estimated to be 69% (95% CI: 46%-97%) higher in 2014 (161,000) if the model was calibrated only to HIV prevalence data. In the 2000-2014 period, the South African ART programme is estimated to have reduced the cumulative number of HIV deaths in adults by 1.72 million (95% CI: 1.58 million-1.84 million) and to have saved 6.15 million life years in adults (95% CI: 5.52 million-6.69 million). This compares with a potential saving of 8.80 million (95% CI: 7.90 million-9.59 million) life years that might have been achieved if South Africa had moved swiftly to implement WHO guidelines (2004-2013) and had achieved high levels of ART uptake in HIV-diagnosed individuals from 2004 onwards. The model is limited by its reliance on all-cause mortality data, given the lack of reliable cause-of-death reporting, and also does not allow for changes over time in tuberculosis control programmes and ART effectiveness. ART has had a dramatic impact on adult mortality in South Africa, but delays in the rollout of ART, especially in the early stages of the ART programme, have contributed to substantial loss of life. This is the first study to our knowledge to calibrate a model of ART impact to population-level recorded death data in Africa; models that are not calibrated to population-level death data may overestimate HIV-related mortality. Substantial reductions in adult mortality have been observed in South Africa since the mid-2000s, but there has been no formal evaluation of how much of this decline is attributable to the scale-up of antiretroviral treatment (ART), as previous models have not been calibrated to vital registration data. We developed a deterministic mathematical model to simulate the mortality trends that would have been expected in the absence of ART, and with earlier introduction of ART.BACKGROUNDSubstantial reductions in adult mortality have been observed in South Africa since the mid-2000s, but there has been no formal evaluation of how much of this decline is attributable to the scale-up of antiretroviral treatment (ART), as previous models have not been calibrated to vital registration data. We developed a deterministic mathematical model to simulate the mortality trends that would have been expected in the absence of ART, and with earlier introduction of ART.Model estimates of mortality rates in ART patients were obtained from the International Epidemiology Databases to Evaluate AIDS-Southern Africa (IeDEA-SA) collaboration. The model was calibrated to HIV prevalence data (1997-2013) and mortality data from the South African vital registration system (1997-2014), using a Bayesian approach. In the 1985-2014 period, 2.70 million adult HIV-related deaths occurred in South Africa. Adult HIV deaths peaked at 231,000 per annum in 2006 and declined to 95,000 in 2014, a reduction of 74.7% (95% CI: 73.3%-76.1%) compared to the scenario without ART. However, HIV mortality in 2014 was estimated to be 69% (95% CI: 46%-97%) higher in 2014 (161,000) if the model was calibrated only to HIV prevalence data. In the 2000-2014 period, the South African ART programme is estimated to have reduced the cumulative number of HIV deaths in adults by 1.72 million (95% CI: 1.58 million-1.84 million) and to have saved 6.15 million life years in adults (95% CI: 5.52 million-6.69 million). This compares with a potential saving of 8.80 million (95% CI: 7.90 million-9.59 million) life years that might have been achieved if South Africa had moved swiftly to implement WHO guidelines (2004-2013) and had achieved high levels of ART uptake in HIV-diagnosed individuals from 2004 onwards. The model is limited by its reliance on all-cause mortality data, given the lack of reliable cause-of-death reporting, and also does not allow for changes over time in tuberculosis control programmes and ART effectiveness.METHODS AND FINDINGSModel estimates of mortality rates in ART patients were obtained from the International Epidemiology Databases to Evaluate AIDS-Southern Africa (IeDEA-SA) collaboration. The model was calibrated to HIV prevalence data (1997-2013) and mortality data from the South African vital registration system (1997-2014), using a Bayesian approach. In the 1985-2014 period, 2.70 million adult HIV-related deaths occurred in South Africa. Adult HIV deaths peaked at 231,000 per annum in 2006 and declined to 95,000 in 2014, a reduction of 74.7% (95% CI: 73.3%-76.1%) compared to the scenario without ART. However, HIV mortality in 2014 was estimated to be 69% (95% CI: 46%-97%) higher in 2014 (161,000) if the model was calibrated only to HIV prevalence data. In the 2000-2014 period, the South African ART programme is estimated to have reduced the cumulative number of HIV deaths in adults by 1.72 million (95% CI: 1.58 million-1.84 million) and to have saved 6.15 million life years in adults (95% CI: 5.52 million-6.69 million). This compares with a potential saving of 8.80 million (95% CI: 7.90 million-9.59 million) life years that might have been achieved if South Africa had moved swiftly to implement WHO guidelines (2004-2013) and had achieved high levels of ART uptake in HIV-diagnosed individuals from 2004 onwards. The model is limited by its reliance on all-cause mortality data, given the lack of reliable cause-of-death reporting, and also does not allow for changes over time in tuberculosis control programmes and ART effectiveness.ART has had a dramatic impact on adult mortality in South Africa, but delays in the rollout of ART, especially in the early stages of the ART programme, have contributed to substantial loss of life. This is the first study to our knowledge to calibrate a model of ART impact to population-level recorded death data in Africa; models that are not calibrated to population-level death data may overestimate HIV-related mortality.CONCLUSIONSART has had a dramatic impact on adult mortality in South Africa, but delays in the rollout of ART, especially in the early stages of the ART programme, have contributed to substantial loss of life. This is the first study to our knowledge to calibrate a model of ART impact to population-level recorded death data in Africa; models that are not calibrated to population-level death data may overestimate HIV-related mortality.
Audience	Academic
Author	May, Margaret T. Egger, Matthias Cornell, Morna Dorrington, Rob E. Johnson, Leigh F. Boulle, Andrew Davies, Mary-Ann
AuthorAffiliation	1 Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa 3 Centre for Actuarial Research, University of Cape Town, Cape Town, South Africa 4 Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland Centers for Disease Control and Prevention, UNITED STATES 2 School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom
AuthorAffiliation_xml	– name: 4 Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland – name: 3 Centre for Actuarial Research, University of Cape Town, Cape Town, South Africa – name: 2 School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom – name: 1 Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa – name: Centers for Disease Control and Prevention, UNITED STATES
Author_xml	– sequence: 1 givenname: Leigh F. orcidid: 0000-0002-2717-011X surname: Johnson fullname: Johnson, Leigh F. – sequence: 2 givenname: Margaret T. orcidid: 0000-0002-9733-1003 surname: May fullname: May, Margaret T. – sequence: 3 givenname: Rob E. surname: Dorrington fullname: Dorrington, Rob E. – sequence: 4 givenname: Morna orcidid: 0000-0001-7149-8799 surname: Cornell fullname: Cornell, Morna – sequence: 5 givenname: Andrew surname: Boulle fullname: Boulle, Andrew – sequence: 6 givenname: Matthias surname: Egger fullname: Egger, Matthias – sequence: 7 givenname: Mary-Ann surname: Davies fullname: Davies, Mary-Ann
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/29232366$$D View this record in MEDLINE/PubMed
BookMark	eNqVk11r1EAUhoNU7If-A9GAIHqx63wkk6QXwlKqFooFq94Ok_nYnZLMbGcmxeKf98Tdld2yiJKLhDnPec-c9-QcZwfOO51lzzGaYlrhdzd-CE5002Wv1RQjRApWP8qOcFk0E8wqdrD1fZgdx3gDTIMa9CQ7JA2hhDJ2lP08j8n2Ilk3z9NC57ZfCplyb3Lhkg06BX9ng-jyFLRIvXYQc7lQQ5fy3ockOpvux6BTMbcuv_ZDWuQzE6wUp_ksB-mFHvUlaPRe6a4bS8U0qPun2WMjuqifrd8n2bcP51_PPk0urz5enM0uJ7JiRZqQ2iCGkFCaqdY0jGDa0qomipTG1EZrXTLZlsjUbcWYII2ihBRV3WJJW90yepK9XOkuOx_52rfIcVPXiNa4QUBcrAjlxQ1fBnAk3HMvLP994MOciwA9dJpLJDEuFC1EXRWtIUJShlRZIlE0oq0FaL1fVxtaGI0Ey8C_HdHdiLMLPvd3vKwIY7gAgTdrgeBvBx0T722UYJxw2g_jvcEW2rC6AvTVA3R_d2tqLqAB64yHunIU5bOSoIaCWxSoyR5qrp2GS8KvZywc7_DTPTw8SvdW7k14u5MATNI_0lwMMfKL6y__wX7-d_bq-y77eotdaNGlRfTdkKx3cRd8sT3FP-PbbA4ApytABh9j0IZLm8SoAzbYjmPExzXdDISPa8rXawrJxYPkjf5f034BfvpBVQ
CitedBy_id	crossref_primary_10_1136_bmjgh_2024_017171 crossref_primary_10_1038_s41586_019_1200_9 crossref_primary_10_1093_mmy_myaa100 crossref_primary_10_1590_s2237_96222022000200021 crossref_primary_10_1007_s10461_021_03263_3 crossref_primary_10_1002_jia2_25476 crossref_primary_10_1002_jia2_25631 crossref_primary_10_1007_s10461_024_04300_7 crossref_primary_10_1016_j_ssmqr_2022_100148 crossref_primary_10_1371_journal_pmed_1002678 crossref_primary_10_1186_s12889_024_19253_8 crossref_primary_10_4054_DemRes_2022_46_18 crossref_primary_10_3390_biology10020108 crossref_primary_10_2989_16085906_2018_1544573 crossref_primary_10_1186_s12879_019_4287_6 crossref_primary_10_1177_0282423X241244670 crossref_primary_10_3390_bioengineering6010024 crossref_primary_10_1542_peds_2020_032490 crossref_primary_10_2147_TCRM_S227290 crossref_primary_10_1097_QAD_0000000000002358 crossref_primary_10_1371_journal_pmed_1003537 crossref_primary_10_1097_QAD_0000000000002355 crossref_primary_10_1097_QAI_0000000000003321 crossref_primary_10_1097_QAD_0000000000003442 crossref_primary_10_3390_biomedicines10081861 crossref_primary_10_1371_journal_pcbi_1007083 crossref_primary_10_1136_bjo_2022_322456 crossref_primary_10_4102_hsag_v28i0_2135 crossref_primary_10_1016_j_cmi_2021_08_002 crossref_primary_10_4102_sajid_v40i1_679 crossref_primary_10_1002_jia2_25650 crossref_primary_10_3389_fneur_2020_00243 crossref_primary_10_1097_MD_0000000000020328 crossref_primary_10_4102_sajhivmed_v22i1_1237 crossref_primary_10_1371_journal_pone_0242595 crossref_primary_10_1016_S2468_2667_24_00020_3 crossref_primary_10_1002_jia2_25649 crossref_primary_10_1080_03066150_2018_1518320 crossref_primary_10_1097_QAD_0000000000003349 crossref_primary_10_1007_s10461_021_03366_x crossref_primary_10_1039_C8CP01843J crossref_primary_10_1371_journal_pmed_1004407 crossref_primary_10_1080_0376835X_2020_1835609 crossref_primary_10_4102_sajhivmed_v22i1_1184 crossref_primary_10_1371_journal_pmed_1002469 crossref_primary_10_1097_QAD_0000000000003068 crossref_primary_10_1186_s12960_021_00567_2 crossref_primary_10_1371_journal_pmed_1003037 crossref_primary_10_1177_02685809241240971 crossref_primary_10_1371_journal_pmed_1003397 crossref_primary_10_1097_QAI_0000000000003491 crossref_primary_10_1186_s12889_021_10962_y crossref_primary_10_1089_aid_2020_0273 crossref_primary_10_1007_s10461_022_03772_9 crossref_primary_10_4102_sajhivmed_v23i1_1377 crossref_primary_10_1002_jia2_26522 crossref_primary_10_1038_s41598_021_95331_w crossref_primary_10_1155_arat_8874741 crossref_primary_10_3389_fpsyg_2022_805289 crossref_primary_10_1136_jech_2021_217480 crossref_primary_10_2989_16085906_2021_1951310 crossref_primary_10_1371_journal_pone_0230105 crossref_primary_10_1016_j_vaccine_2019_09_059 crossref_primary_10_1186_s12879_023_08217_9 crossref_primary_10_1002_jia2_25784 crossref_primary_10_1111_irv_12987 crossref_primary_10_1016_S0140_6736_18_31070_5 crossref_primary_10_1016_S2352_3018_22_00192_8 crossref_primary_10_1080_21528586_2019_1666736 crossref_primary_10_1371_journal_pone_0249953 crossref_primary_10_2196_40796 crossref_primary_10_1371_journal_pone_0259073 crossref_primary_10_1371_journal_pone_0203638 crossref_primary_10_1080_17450128_2019_1619891 crossref_primary_10_1111_bcp_14768 crossref_primary_10_1007_s10461_021_03284_y crossref_primary_10_1016_j_socscimed_2022_114832 crossref_primary_10_1136_bmjgh_2023_014912 crossref_primary_10_1016_S2352_3018_24_00124_3 crossref_primary_10_7189_jogh_15_04108 crossref_primary_10_1002_jia2_25854 crossref_primary_10_1371_journal_pmed_1003107 crossref_primary_10_4102_sajo_v6i0_211 crossref_primary_10_1371_journal_pmed_1004330 crossref_primary_10_1136_bmjgh_2020_004089 crossref_primary_10_1371_journal_pone_0217014 crossref_primary_10_1080_16549716_2020_1792192 crossref_primary_10_1371_journal_pone_0267159 crossref_primary_10_3389_fphar_2024_1304950 crossref_primary_10_1093_cid_ciab095 crossref_primary_10_1136_bmjgh_2024_017268 crossref_primary_10_7861_clinmedicine_19_2_145 crossref_primary_10_1002_jia2_26413 crossref_primary_10_1002_jia2_25686 crossref_primary_10_1186_s12889_022_14730_4 crossref_primary_10_1212_CPJ_0000000000200198 crossref_primary_10_1186_s12913_022_08506_0 crossref_primary_10_4102_sajo_v6i0_220 crossref_primary_10_1038_s41598_022_25064_x
Cites_doi	10.1097/QAI.0b013e3181e7744e 10.1093/ije/dys164 10.1097/QAD.0000000000000496 10.1093/infdis/jir747 10.1007/s10461-014-0920-y 10.1371/journal.pmed.1002107 10.7196/SAMJ.7689 10.1371/journal.pone.0001711 10.7448/IAS.18.1.20628 10.1016/S2214-109X(15)00080-7 10.1371/journal.pone.0025310 10.1016/S0140-6736(08)60693-5 10.1093/cid/cis1000 10.1097/QAD.0b013e32831c5497 10.2471/BLT.07.045294 10.1371/journal.pone.0100431 10.1016/S0140-6736(00)02061-4 10.1016/S2352-3018(14)00002-2 10.1111/j.1365-3156.2011.02828.x 10.1371/journal.pcbi.1003673 10.1136/sextrans-2012-050640 10.1371/journal.ppat.1001196 10.2471/BLT.11.086280 10.1016/S0140-6736(94)90631-9 10.1097/QAD.0000000000001197 10.1111/tmi.12434 10.1371/journal.pmed.1001418 10.1371/journal.pmed.1002015 10.1111/j.1465-7295.2010.00273.x 10.4102/sajhivmed.v17i1.459 10.1016/S2352-3018(16)30087-X 10.1097/QAD.0000000000000947 10.1371/journal.pmed.1001718 10.1098/rsif.2015.0888 10.1097/QAD.0000000000001014 10.7554/eLife.20492 10.3402/gha.v9.30314 10.1056/NEJM200003303421303 10.1097/01.aids.0000299405.06658.a8 10.1073/pnas.1413339111 10.1136/bmj.313.7057.583 10.1097/QAD.0000000000001068 10.1111/j.1541-0420.2010.01399.x 10.1093/acprof:oso/9780198718048.001.0001 10.1016/S0140-6736(06)68337-2 10.1097/QAD.0b013e32834db418 10.1097/00042560-199806010-00007 10.1136/sextrans-2012-050658 10.1371/journal.pcbi.1002185 10.1371/journal.pone.0005790 10.1086/503258 10.4102/sajhivmed.v16i1.367 10.1093/ije/dyr080 10.1097/01.aids.0000299411.75269.e8 10.1371/journal.pmed.1001905 10.1093/afraf/adm087 10.1097/00002030-200105040-00009 10.1007/s00285-008-0177-z 10.1093/ije/dyu156 10.1097/QAD.0b013e3280f00fb3 10.1016/S2352-3018(16)30225-9 10.1016/S0140-6736(07)61307-5 10.1086/427656 10.1098/rsif.2011.0826 10.1371/journal.pcbi.1003459 10.1007/s12546-011-9050-9 10.4102/sajhivmed.v18i1.694 10.1089/088922201750290023 10.1097/QAD.0b013e328017f857 10.1097/QAI.0000000000000192 10.1016/S2214-109X(16)30113-9
ContentType	Journal Article
Copyright	COPYRIGHT 2017 Public Library of Science 2017 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Johnson LF, May MT, Dorrington RE, Cornell M, Boulle A, Egger M, et al. (2017) Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study. PLoS Med 14(12): e1002468. https://doi.org/10.1371/journal.pmed.1002468 2017 Johnson et al 2017 Johnson et al 2017 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Johnson LF, May MT, Dorrington RE, Cornell M, Boulle A, Egger M, et al. (2017) Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study. PLoS Med 14(12): e1002468. https://doi.org/10.1371/journal.pmed.1002468
Copyright_xml	– notice: COPYRIGHT 2017 Public Library of Science – notice: 2017 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Johnson LF, May MT, Dorrington RE, Cornell M, Boulle A, Egger M, et al. (2017) Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study. PLoS Med 14(12): e1002468. https://doi.org/10.1371/journal.pmed.1002468 – notice: 2017 Johnson et al 2017 Johnson et al – notice: 2017 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Johnson LF, May MT, Dorrington RE, Cornell M, Boulle A, Egger M, et al. (2017) Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study. PLoS Med 14(12): e1002468. https://doi.org/10.1371/journal.pmed.1002468
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISN ISR 3V. 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA CZK
DOI	10.1371/journal.pmed.1002468
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Canada Gale In Context: Science ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection (UHCL Subscription) Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journal Collection PLoS Medicine
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	Publicly Available Content Database MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
DocumentTitleAlternate	Estimating antiretroviral treatment impact on mortality trends in South Africa
EISSN	1549-1676
ExternalDocumentID	1988038190 oai_doaj_org_article_c0c114d34a874bf2ac360d550a49ab8a PMC5726614 A520932473 29232366 10_1371_journal_pmed_1002468
Genre	Journal Article
GeographicLocations	South Africa
GeographicLocations_xml	– name: South Africa
GrantInformation_xml	– fundername: NIAID NIH HHS grantid: U01 AI069924 – fundername: ; – fundername: ; grantid: U01 AI069924
GroupedDBID	--- 123 29O 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAUCC AAWOE AAWTL AAYXX ABDBF ABUWG ACCTH ACGFO ACIHN ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AFFHD AFKRA AFPKN AFRAH AFXKF AHMBA AKRSQ ALMA_UNASSIGNED_HOLDINGS AOIJS B0M BAIFH BAWUL BBTPI BCNDV BENPR BPHCQ BVXVI BWKFM CCPQU CITATION CS3 DIK DU5 E3Z EAP EAS EBD EBS EJD EMK EMOBN ESX F5P FPL FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR IOF IOV IPO ISN ISR ITC KQ8 M1P M48 MK0 O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PV9 RNS RPM RZL SV3 TR2 TUS UKHRP WOW XSB YZZ ~8M ALIPV CGR CUY CVF ECM EIF H13 IPNFZ NPM RIG WOQ 3V. 7TK 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI 7X8 PUEGO 5PM AAPBV ABPTK BCGST CZK ICW M~E
ID	FETCH-LOGICAL-c764t-28f0600ade6dbf96213b3782d25ff8feee56cb50f8b766a29d322478b1c3beb63
IEDL.DBID	FPL
ISICitedReferencesCount	117
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000418946400005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1549-1676 1549-1277
IngestDate	Sun Jul 02 11:04:24 EDT 2023 Mon Nov 10 04:35:54 EST 2025 Tue Nov 04 01:51:22 EST 2025 Thu Sep 04 18:29:29 EDT 2025 Sat Nov 29 14:35:29 EST 2025 Tue Nov 11 10:03:03 EST 2025 Sat Nov 29 11:12:09 EST 2025 Tue Nov 04 17:55:11 EST 2025 Thu Nov 13 14:51:50 EST 2025 Thu Nov 13 15:26:49 EST 2025 Thu Nov 13 15:36:25 EST 2025 Thu May 22 21:05:26 EDT 2025 Thu Apr 03 07:08:38 EDT 2025 Sat Nov 29 05:16:29 EST 2025 Tue Nov 18 22:13:51 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	12
Language	English
License	This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c764t-28f0600ade6dbf96213b3782d25ff8feee56cb50f8b766a29d322478b1c3beb63
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 The authors have read the journal's policy and declare the following competing interests: MM received grants from the Newton Fund and the Worldwide Universities Network for a research visit to the University of Cape Town directly related to this work and also from the UK Medical Research Council (MRC) [grant number MR/J002380/1] and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement which is part of the EDCTP2 programme supported by the European Union for work on HIV prognosis in the last 5 years. ME receives a stipend as a specialty consulting editor for PLOS Medicine and serves on the journal's editorial board.
ORCID	0000-0002-9733-1003 0000-0001-7149-8799 0000-0002-2717-011X
OpenAccessLink	http://dx.doi.org/10.1371/journal.pmed.1002468
PMID	29232366
PQID	1988038190
PQPubID	1436338
ParticipantIDs	plos_journals_1988038190 doaj_primary_oai_doaj_org_article_c0c114d34a874bf2ac360d550a49ab8a pubmedcentral_primary_oai_pubmedcentral_nih_gov_5726614 proquest_miscellaneous_1976439687 proquest_journals_1988038190 gale_infotracmisc_A520932473 gale_infotracgeneralonefile_A520932473 gale_infotracacademiconefile_A520932473 gale_incontextgauss_ISR_A520932473 gale_incontextgauss_ISN_A520932473 gale_incontextgauss_IOV_A520932473 gale_healthsolutions_A520932473 pubmed_primary_29232366 crossref_citationtrail_10_1371_journal_pmed_1002468 crossref_primary_10_1371_journal_pmed_1002468
PublicationCentury	2000
PublicationDate	20171212
PublicationDateYYYYMMDD	2017-12-12
PublicationDate_xml	– month: 12 year: 2017 text: 20171212 day: 12
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States – name: San Francisco – name: San Francisco, CA USA
PublicationTitle	PLoS medicine
PublicationTitleAlternate	PLoS Med
PublicationYear	2017
Publisher	Public Library of Science Public Library of Science (PLoS)
Publisher_xml	– name: Public Library of Science – name: Public Library of Science (PLoS)
References	RE Dorrington (ref23) 2011; 28 (ref59) 2015 JK Birnbaum (ref74) 2011; 89 S Wandel (ref37) 2008; 84 A Boulle (ref16) 2014; 11 TR O’Brien (ref31) 1998; 18 LF Johnson (ref9) 2012; 9 SG Mahiane (ref50) 2009; 23 N Bacaër (ref81) 2008; 57 MT May (ref15) 2012; 41 P Pezzotti (ref41) 1996; 313 GJ Churchyard (ref82) 2014; 104 (ref1) 2015 S Charalambous (ref69) 2016; 30 J Todd (ref35) 2007; 21 US Fideli (ref34) 2001; 17 LF Johnson (ref28) 2017; 18 LF Johnson (ref22) 2015; 18 JW Eaton (ref63) 2015; 3 A Hansmann (ref29) 2005; 38 LS Burch (ref68) 2016; 30 LS Wilkinson (ref71) 2015; 20 J Joubert (ref73) 2014; 43 N Nattrass (ref27) 2008; 107 RS Hogg (ref40) 1994; 344 O Shisana (ref54) 2014 L Lavreys (ref30) 2006; 42 JP Hughes (ref32) 2012; 205 G Reniers (ref83) 2017; 4 F Blanquart (ref13) 2016; 5 (ref25) 2014 N Pantazis (ref44) 2014; 1 HE Roberts (ref76) 2015; 12 T Quinn (ref33) 2000; 342 R Payne (ref12) 2014; 111 G Reniers (ref5) 2014; 28 PW Setel (ref21) 2007; 370 A Jahn (ref6) 2008; 371 S Rosen (ref86) 2016; 13 D Bradshaw (ref2) 2016; 30 R Isingo (ref39) 2007; 21 M Egger (ref26) 2012; 41 M Haacker (ref80) 2016 J Stover (ref18) 2012; 88 K Kranzer (ref72) 2011; 16 IT Katz (ref88) 2015; 19 HR Fryer (ref67) 2010; 6 JT Herbeck (ref42) 2012; 26 AE Pettifor (ref48) 2007; 21 R Dorrington (ref3) 2014 (ref38) 2000; 355 NJ Nagelkerke (ref10) 2014; 10 V Pillay-van Wyk (ref4) 2016; 4 MW Brinkhof (ref20) 2009; 4 P Braitstein (ref17) 2006; 367 E Oster (ref64) 2010; 10 R Stoneburner (ref7) 2014; 9 (ref11) 2013 G Shirreff (ref66) 2011; 7 MA Adam (ref46) 2009; 99 (ref57) 2009 RE Dorrington (ref53) 2004 S Gupta (ref60) 2016; 17 H Wang (ref62) 2016; 3 JT Herbeck (ref77) 2014; 10 B Lopman (ref65) 2008; 3 RE Dorrington (ref24) 2016 G Touloumi (ref43) 2013; 56 L Wilkinson (ref87) 2015; 16 B Auvert (ref49) 2001; 15 CT Yiannoutsos (ref14) 2012; 88 (ref58) 2013 H Küstner (ref47) 1994; 84 V Vella (ref70) 2010; 55 JR Glynn (ref36) 2007; 21 LF Johnson (ref75) 2016; 30 LF Johnson (ref52) 2013; 10 J Bor (ref85) 2015; 12 JM Baeten (ref51) 2005; 191 (ref56) 2004 A Mujugira (ref61) 2014; 66 LF Johnson (ref19) 2016; 9 AE Raftery (ref55) 2010; 66 A Boulle (ref45) 2008; 86 S Resch (ref78) 2011; 6 CC Iwuji (ref84) 2016; 13 G Asiki (ref8) 2016; 30 PC Ferreira (ref79) 2011; 49 29232374 - PLoS Med. 2017 Dec 12;14(12):e1002469
References_xml	– volume: 55 start-page: 109 year: 2010 ident: ref70 article-title: Retrospective study on the critical factors for retaining patients on antiretroviral therapy in KwaZulu-Natal, South Africa publication-title: J Acquir Immun Defic Syndr doi: 10.1097/QAI.0b013e3181e7744e – volume: 41 start-page: 1807 year: 2012 ident: ref15 article-title: Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics publication-title: Int J Epidemiol doi: 10.1093/ije/dys164 – volume: 28 start-page: S533 issue: Suppl 4 year: 2014 ident: ref5 article-title: Mortality trends in the era of antiretroviral therapy: evidence from the Network for Analysing Longitudinal Population based HIV/AIDS data on Africa (ALPHA) publication-title: AIDS doi: 10.1097/QAD.0000000000000496 – volume: 205 start-page: 358 year: 2012 ident: ref32 article-title: Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples publication-title: J Infect Dis doi: 10.1093/infdis/jir747 – volume: 19 start-page: 704 year: 2015 ident: ref88 article-title: Understanding treatment refusal among adults presenting for HIV-testing in Soweto, South Africa: a qualitative study publication-title: AIDS Behav doi: 10.1007/s10461-014-0920-y – volume: 13 start-page: e1002107 issue: 8 year: 2016 ident: ref84 article-title: Uptake of home-based HIV testing, linkage to care, and community attitudes about ART in rural KwaZulu-Natal, South Africa: descriptive results from the first phase of the ANRS 12249 TasP cluster-randomised trial publication-title: PLoS Med doi: 10.1371/journal.pmed.1002107 – volume: 104 start-page: 244 year: 2014 ident: ref82 article-title: Tuberculosis control in South Africa: successes, challenges and recommendations publication-title: S Afr Med J doi: 10.7196/SAMJ.7689 – volume: 3 start-page: e1711 issue: 3 year: 2008 ident: ref65 article-title: When did HIV incidence peak in Harare, Zimbabwe? Back-calculation from mortality statistics publication-title: PLoS ONE doi: 10.1371/journal.pone.0001711 – volume: 18 start-page: 20628 year: 2015 ident: ref22 article-title: A comparison of death recording by health centres and civil registration in South Africans receiving antiretroviral treatment publication-title: J Int AIDS Soc doi: 10.7448/IAS.18.1.20628 – volume: 3 start-page: e598 year: 2015 ident: ref63 article-title: Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral therapy era publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(15)00080-7 – volume: 6 start-page: e25310 issue: 10 year: 2011 ident: ref78 article-title: Economic returns to investment in AIDS treatment in low and middle income countries publication-title: PLoS ONE doi: 10.1371/journal.pone.0025310 – volume: 371 start-page: 1603 year: 2008 ident: ref6 article-title: Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi publication-title: Lancet doi: 10.1016/S0140-6736(08)60693-5 – volume: 56 start-page: 888 year: 2013 ident: ref43 article-title: Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts publication-title: Clin Infect Dis doi: 10.1093/cid/cis1000 – volume: 23 start-page: 377 year: 2009 ident: ref50 article-title: Transmission probabilities of HIV and herpes simplex virus type 2, effect of male circumcision and interaction: a longitudinal study in a township of South Africa publication-title: AIDS doi: 10.1097/QAD.0b013e32831c5497 – volume: 86 start-page: 678 year: 2008 ident: ref45 article-title: Antiretroviral therapy and early mortality in South Africa publication-title: Bull World Health Organ doi: 10.2471/BLT.07.045294 – volume: 9 start-page: e100431 issue: 7 year: 2014 ident: ref7 article-title: Using health surveillance systems data to assess the impact of AIDS and antiretroviral treatment on adult morbidity and mortality in Botswana publication-title: PLoS ONE doi: 10.1371/journal.pone.0100431 – volume: 355 start-page: 1131 year: 2000 ident: ref38 article-title: Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe publication-title: Lancet doi: 10.1016/S0140-6736(00)02061-4 – volume: 1 start-page: e119 year: 2014 ident: ref44 article-title: Temporal trends in prognostic markers of HIV-1 virulence and transmissibility: an observational cohort study publication-title: Lancet HIV doi: 10.1016/S2352-3018(14)00002-2 – volume: 10 start-page: 80 year: 2010 ident: ref64 article-title: Estimating HIV prevalence and incidence in Africa from mortality data publication-title: B E J Econom Anal Policy – volume: 16 start-page: 1297 year: 2011 ident: ref72 article-title: Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review publication-title: Trop Med Int Health doi: 10.1111/j.1365-3156.2011.02828.x – volume: 10 start-page: e1003673 issue: 6 year: 2014 ident: ref77 article-title: An HIV epidemic model based on viral load dynamics: value in assessing empirical trends in HIV virulence and community viral load publication-title: PLoS Comput Biol doi: 10.1371/journal.pcbi.1003673 – volume: 88 start-page: i11 issue: Suppl 2 year: 2012 ident: ref18 article-title: Updates to the Spectrum/Estimation and Projection Package (EPP) model to estimate HIV trends for adults and children publication-title: Sex Transm Infect doi: 10.1136/sextrans-2012-050640 – volume: 38 start-page: 335 year: 2005 ident: ref29 article-title: Baseline plasma viral load and CD4 cell percentage predict survival in HIV-1- and HIV-2-infected women in a community-based cohort in the Gambia publication-title: J Acquir Immun Defic Syndr – year: 2013 ident: ref58 article-title: Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach – volume: 84 start-page: 195 year: 1994 ident: ref47 article-title: National HIV surveillance—South Africa, 1990–1992 publication-title: S Afr Med J – volume: 6 start-page: e1001196 issue: 11 year: 2010 ident: ref67 article-title: Modelling the evolution and spread of HIV immune escape mutants publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1001196 – volume: 30 start-page: 487 year: 2016 ident: ref8 article-title: Adult life expectancy trends in the era of antiretroviral treatment in rural Uganda (1991–2012) publication-title: AIDS – volume: 89 start-page: 278 year: 2011 ident: ref74 article-title: Exposing misclassified HIV/AIDS deaths in South Africa publication-title: Bull World Health Organ doi: 10.2471/BLT.11.086280 – volume: 344 start-page: 1120 year: 1994 ident: ref40 article-title: Lower socioeconomic status and shorter survival following HIV infection publication-title: Lancet doi: 10.1016/S0140-6736(94)90631-9 – volume: 30 start-page: 2545 year: 2016 ident: ref75 article-title: Life expectancy trends in adults on antiretroviral treatment in South Africa publication-title: AIDS doi: 10.1097/QAD.0000000000001197 – volume: 20 start-page: 365 year: 2015 ident: ref71 article-title: Self-transfer and mortality amongst adults lost to follow-up in ART programmes in low- and middle-income countries: systematic review and meta-analysis publication-title: Trop Med Int Health doi: 10.1111/tmi.12434 – volume: 10 start-page: e1001418 issue: 4 year: 2013 ident: ref52 article-title: Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies publication-title: PLoS Med doi: 10.1371/journal.pmed.1001418 – volume: 13 start-page: e1002015 issue: 5 year: 2016 ident: ref86 article-title: Initiating antiretroviral therapy for HIV at a patient’s first clinic visit: the RapIT randomized controlled trial publication-title: PLoS Med doi: 10.1371/journal.pmed.1002015 – volume: 49 start-page: 1104 year: 2011 ident: ref79 article-title: The economic impact of AIDS on income and human capital publication-title: Econ Inquiry doi: 10.1111/j.1465-7295.2010.00273.x – volume: 17 start-page: a459 year: 2016 ident: ref60 article-title: When will sub-Saharan Africa adopt HIV treatment for all? publication-title: South Afr J HIV Med doi: 10.4102/sajhivmed.v17i1.459 – year: 2015 ident: ref1 article-title: Statistics South Africa. Mortality and causes of death in South Africa, 2014: findings from death notification – year: 2014 ident: ref54 article-title: South African national HIV prevalence, incidence, and behaviour survey, 2012 – volume: 3 start-page: e361 year: 2016 ident: ref62 article-title: Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 publication-title: Lancet HIV doi: 10.1016/S2352-3018(16)30087-X – volume: 30 start-page: 771 year: 2016 ident: ref2 article-title: HIV/AIDS in South Africa: how many people died from the disease between 1997 and 2010? publication-title: AIDS doi: 10.1097/QAD.0000000000000947 – year: 2014 ident: ref3 article-title: Rapid mortality surveillance report 2012 – volume: 11 start-page: e1001718 issue: 9 year: 2014 ident: ref16 article-title: Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies publication-title: PLoS Med doi: 10.1371/journal.pmed.1001718 – year: 2004 ident: ref56 article-title: Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach—2003 revision – volume: 12 start-page: 20150888 year: 2015 ident: ref76 article-title: The impact of antiretroviral therapy on population-level virulence evolution of HIV-1 publication-title: J Roy Soc Interface doi: 10.1098/rsif.2015.0888 – year: 2015 ident: ref59 article-title: Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV – year: 2013 ident: ref11 article-title: Joint United Nations Programme on HIV/AIDS. Global report: UNAIDS report on the global AIDS epidemic 2013 – volume: 30 start-page: 1099 year: 2016 ident: ref69 article-title: Clinic-level factors influencing patient outcomes on antiretroviral therapy in primary health clinics in South Africa publication-title: AIDS doi: 10.1097/QAD.0000000000001014 – volume: 5 start-page: e20492 year: 2016 ident: ref13 article-title: A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda publication-title: Elife doi: 10.7554/eLife.20492 – volume: 9 start-page: 30314 year: 2016 ident: ref19 article-title: Prospects for HIV control in South Africa: a model-based analysis publication-title: Glob Health Action doi: 10.3402/gha.v9.30314 – volume: 342 start-page: 921 year: 2000 ident: ref33 article-title: Viral load and heterosexual transmission of human immunodeficiency virus type 1 publication-title: N Engl J Med doi: 10.1056/NEJM200003303421303 – volume: 21 start-page: S5 issue: Suppl 6 year: 2007 ident: ref39 article-title: Survival after HIV infection in the pre-antiretroviral therapy era in a rural Tanzanian cohort publication-title: AIDS doi: 10.1097/01.aids.0000299405.06658.a8 – volume: 111 start-page: E5393 year: 2014 ident: ref12 article-title: Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1413339111 – volume: 313 start-page: 583 year: 1996 ident: ref41 article-title: Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion publication-title: BMJ doi: 10.1136/bmj.313.7057.583 – year: 2009 ident: ref57 article-title: Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents – volume: 30 start-page: 1147 year: 2016 ident: ref68 article-title: Socioeconomic status and response to antiretroviral therapy in high-income countries: a literature review publication-title: AIDS doi: 10.1097/QAD.0000000000001068 – year: 2014 ident: ref25 article-title: Statistics South Africa. Mortality and causes of death in South Africa, 2011: findings from death notification – volume: 66 start-page: 1162 year: 2010 ident: ref55 article-title: Estimating and projecting trends in HIV/AIDS generalized epidemics using incremental mixture importance sampling publication-title: Biometrics doi: 10.1111/j.1541-0420.2010.01399.x – year: 2016 ident: ref80 article-title: The economics of the global response to HIV/AIDS doi: 10.1093/acprof:oso/9780198718048.001.0001 – volume: 367 start-page: 817 year: 2006 ident: ref17 article-title: Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries publication-title: Lancet doi: 10.1016/S0140-6736(06)68337-2 – volume: 26 start-page: 193 year: 2012 ident: ref42 article-title: Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission publication-title: AIDS doi: 10.1097/QAD.0b013e32834db418 – volume: 18 start-page: 155 year: 1998 ident: ref31 article-title: Longitudinal HIV-1 RNA levels in a cohort of homosexual men publication-title: J Acquir Immun Defic Syndr doi: 10.1097/00042560-199806010-00007 – volume: 88 start-page: i33 issue: Suppl 2 year: 2012 ident: ref14 article-title: Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy publication-title: Sex Transm Infect doi: 10.1136/sextrans-2012-050658 – volume: 7 start-page: e1002185 issue: 10 year: 2011 ident: ref66 article-title: Transmission selects for HIV-1 strains of intermediate virulence: a modelling approach publication-title: PLoS Comput Biol doi: 10.1371/journal.pcbi.1002185 – volume: 4 start-page: e5790 issue: 6 year: 2009 ident: ref20 article-title: Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis publication-title: PLoS ONE doi: 10.1371/journal.pone.0005790 – volume: 42 start-page: 1333 year: 2006 ident: ref30 article-title: Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women publication-title: Clin Infect Dis doi: 10.1086/503258 – volume: 16 start-page: 367 year: 2015 ident: ref87 article-title: Outcomes from the implementation of a counselling model supporting rapid antiretroviral treatment initiation in a primary healthcare clinic in Khayelitsha, South Africa publication-title: South Afr J HIV Med doi: 10.4102/sajhivmed.v16i1.367 – volume: 41 start-page: 1256 year: 2012 ident: ref26 article-title: Cohort profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa publication-title: Int J Epidemiol doi: 10.1093/ije/dyr080 – volume: 21 start-page: S55 issue: Suppl 6 year: 2007 ident: ref35 article-title: Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy publication-title: AIDS doi: 10.1097/01.aids.0000299411.75269.e8 – volume: 12 start-page: e1001905 issue: 11 year: 2015 ident: ref85 article-title: Mass HIV treatment and sex disparities in life expectancy: demographic surveillance in rural South Africa publication-title: PLoS Med doi: 10.1371/journal.pmed.1001905 – volume: 107 start-page: 157 year: 2008 ident: ref27 article-title: AIDS and the scientific governance of medicine in post-apartheid South Africa publication-title: Afr Aff (Lond) doi: 10.1093/afraf/adm087 – volume: 15 start-page: 885 year: 2001 ident: ref49 article-title: HIV infection in a South African mining town is associated with herpes simplex virus-2 seropositivity and sexual behaviour publication-title: AIDS doi: 10.1097/00002030-200105040-00009 – volume: 57 start-page: 557 year: 2008 ident: ref81 article-title: Modeling the joint epidemics of TB and HIV in a South African township publication-title: J Math Biol doi: 10.1007/s00285-008-0177-z – volume: 43 start-page: 1945 year: 2014 ident: ref73 article-title: Record-linkage comparison of verbal autopsy and routine civil registration death certification in rural north-east South Africa: 2006–09 publication-title: Int J Epidemiol doi: 10.1093/ije/dyu156 – year: 2016 ident: ref24 article-title: Rapid mortality surveillance report 2015 – volume: 21 start-page: 861 year: 2007 ident: ref48 article-title: Highly efficient HIV transmission to young women in South Africa publication-title: AIDS doi: 10.1097/QAD.0b013e3280f00fb3 – volume: 4 start-page: e113 year: 2017 ident: ref83 article-title: Trends in the burden of HIV mortality after roll-out of antiretroviral therapy in KwaZulu-Natal, South Africa: an observational community cohort study publication-title: Lancet HIV doi: 10.1016/S2352-3018(16)30225-9 – volume: 370 start-page: 1569 year: 2007 ident: ref21 article-title: A scandal of invisibility: making everyone count by counting everyone publication-title: Lancet doi: 10.1016/S0140-6736(07)61307-5 – volume: 191 start-page: 546 year: 2005 ident: ref51 article-title: Female-to-male infectivity of HIV-1 among circumcised and uncircumcised Kenyan men publication-title: J Infect Dis doi: 10.1086/427656 – volume: 9 start-page: 1544 year: 2012 ident: ref9 article-title: The effect of changes in condom usage and antiretroviral treatment coverage on HIV incidence in South Africa: a model-based analysis publication-title: J Roy Soc Interface doi: 10.1098/rsif.2011.0826 – volume: 10 start-page: e1003459 issue: 3 year: 2014 ident: ref10 article-title: The rise and fall of HIV in high-prevalence countries: a challenge for mathematical modeling publication-title: PLoS Comput Biol doi: 10.1371/journal.pcbi.1003459 – volume: 28 start-page: 49 year: 2011 ident: ref23 article-title: Maternal mortality in South Africa: lessons from a case study in the use of deaths reported by households in censuses and surveys publication-title: J Pop Res doi: 10.1007/s12546-011-9050-9 – year: 2004 ident: ref53 article-title: Estimation of mortality using the South African Census 2001 data. CARe Monograph 11 – volume: 99 start-page: 661 year: 2009 ident: ref46 article-title: Estimation of adult antiretroviral treatment coverage in South Africa publication-title: S Afr Med J – volume: 18 start-page: a694 year: 2017 ident: ref28 article-title: Progress towards the 2020 targets for HIV diagnosis and antiretroviral treatment in South Africa publication-title: South Afr J HIV Med doi: 10.4102/sajhivmed.v18i1.694 – volume: 84 start-page: i31 issue: Suppl i year: 2008 ident: ref37 article-title: Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies publication-title: Sex Transm Infect – volume: 17 start-page: 901 year: 2001 ident: ref34 article-title: Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa publication-title: AIDS Res Hum Retroviruses doi: 10.1089/088922201750290023 – volume: 21 start-page: 625 year: 2007 ident: ref36 article-title: Survival from HIV-1 seroconversion in Southern Africa: a retrospective cohort study in nearly 2000 gold-miners over 10 years of follow-up publication-title: AIDS doi: 10.1097/QAD.0b013e328017f857 – volume: 66 start-page: 436 year: 2014 ident: ref61 article-title: Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships publication-title: J Acquir Immun Defic Syndr doi: 10.1097/QAI.0000000000000192 – volume: 4 start-page: e642 year: 2016 ident: ref4 article-title: Mortality trends and differentials in South Africa from 1997 to 2012: second National Burden of Disease Study publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(16)30113-9 – reference: 29232374 - PLoS Med. 2017 Dec 12;14(12):e1002469
SSID	ssj0029090
Score	2.5686398
Snippet	Substantial reductions in adult mortality have been observed in South Africa since the mid-2000s, but there has been no formal evaluation of how much of this... Background Substantial reductions in adult mortality have been observed in South Africa since the mid-2000s, but there has been no formal evaluation of how... BackgroundSubstantial reductions in adult mortality have been observed in South Africa since the mid-2000s, but there has been no formal evaluation of how much... Leigh Johnson and colleagues model the HIV epidemic in South Africa, using national level health statistics as inputs, to estimate the number of deaths avoided... BACKGROUND:Substantial reductions in adult mortality have been observed in South Africa since the mid-2000s, but there has been no formal evaluation of how... Background Substantial reductions in adult mortality have been observed in South Africa since the mid-2000s, but there has been no formal evaluation of how...
SourceID	plos doaj pubmedcentral proquest gale pubmed crossref
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source
StartPage	e1002468
SubjectTerms	Acquired immune deficiency syndrome Adult Adults AIDS Antiretroviral agents Antiretroviral drugs Antiretroviral therapy Antiretroviral Therapy, Highly Active - methods Bayes Theorem Bayesian analysis Biology and Life Sciences Computer simulation Death Drug therapy Epidemics Epidemiology Fatalities Female Health care Highly active antiretroviral therapy HIV HIV Infections - drug therapy HIV Infections - mortality HIV Infections - transmission Human immunodeficiency virus Humans Infectious diseases Life expectancy Male Mathematical models Medicine and Health Sciences Middle Aged Models, Theoretical Mortality Mortality - trends Patient outcomes People and places Population Preventive medicine Registration South Africa - epidemiology Studies Trends Tuberculosis Young Adult
SummonAdditionalLinks	– databaseName: DOAJ Directory of Open Access Journal Collection dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nj9MwELVQhRAXxPcGFjAIwSlsYqd2wq2gXcGBgvjS3iLbsUul3aTatFz488zYbtSgSrsHrvWLpc54xm8S-w0hL5k0LjONTTPXKChQcoi5QqtUsFznlbR5NQ3NJuR8Xp6eVl92Wn3hmbAgDxwMd2QyA5S94YUqZaEdU4aLrAFerYpK6dJTI2A922IqllpV5t-uoP5YmjMp46U5LvOj6KM3K9htvABpgTKrO5uS1-4fMvRkddb1--jnv6cod7alk9vkVuSTdBb-xx1yzbZ3yY1P8Yv5PfLnGGIYWWm7oMD1aLgVSTtHwaSQ7tb4SgHmpcOJc9q11Kty0HNPzYGm42Db9HTZUt9yj4buQm_pjJ4Psq8wh2-rg_fbqVetvU9-nBx_f_8hjQ0XUiNFsU5Z6TIgQKqxotGuAn9xzYFCNGzqXOmstVNh9DRzpZZCKFY1kA4KWerccG214A_IpO1ae0CoYabIisIowSzsk6XSuW0a8CNHSbWCJYRvLV6bqEaOTTHOav-JTUJVEgxYo5_q6KeEpMNTq6DGcQn-HTpzwKKWtv8BVlgdV1h92QpLyDNcCnW4mDpkhHqGJ4iAj0qekBcegXoaLR7YWahN39cfP_-8Aujb_CqgryPQ6whyHdjMqHiTAiyPYl4j5KsRchGkzPcBD0dAyDFmNHyAYbC1cV_nFeR9LPYzeHIbGvuHnw_DOCke6Wttt0GMRDYsSpmQhyGSBj8xKDsYFyIhchRjI0eOR9rlLy-OPpWecj76H55_TG4yZHE59v85JJP1xcY-IdfN7_Wyv3jqM85fXXCGGg priority: 102 providerName: Directory of Open Access Journals – databaseName: Publicly Available Content Database dbid: PIMPY link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELagixAX3rCBBQxCcApNbDdOuKCCdsUetlS8tHuKHNsplXaT0rRc-PPMOG7YoAr2wLX-EqUez3jGnvmGkOdM6jLSxoZRaRQEKDHonChUmLC4iDNp42zUNpuQk0l6fJxNfXl049MqNzbRGeqW7RnztsEID02t8cR8CKFyindcWfRm8T3EHlJ41-obalwmO0i8lQ7IzvTwaHrSBWBZ5M5ckJUsjJmUvpSOy3joJfdqAXuQoyUVSL56bqtyjP6d3R4sTutmm1P6Z27luc3q4Mb__Zs3yXXvtNJxu8pukUu2uk2uHvlr-Tvk5z4YCnR9qxkFh5K2pZe0LinIDWzqCs8t4DNpl9ZO64o66g965vx_iAVwsDINnVfU9fWjbQuj13RMzzpuWXiH692DRfTUUePeJV8O9j-_ex_6rg6hlolYhSwtI_CylLGJKcoMFgUvOPgpho3KMi2ttaNEF6OoTAuZJIplBmyOkGkRa17YIuH3yKCqK7tLqGZaREJolTALm3GqitgaIwznyNsmWED4RoC59pTn2HnjNHf3eBJCn3YCcxR77sUekLB7atFSfvwD_xbXRodFwm73Q72c5V7_cx1piDwNFyqVoiiZ0jyJDISHSmSqSFVAnuDKytvq187s5GNMUwKnV_KAPHMIJO2oMCtoptZNkx9--HoB0KfJRUAfe6CXHlTWMGda-XINmHlkDOshX_SQs5YvfRtwrwcEQ6Z7w7uoVZs5bvLfqx-e3GjL9uGn3TC-FPMGK1uvESPR5U5SGZD7rWJ2cmIQ2zCeJAGRPZXtCbI_Us2_OQb2kXR-7YO_f9ZDco2hExhj-6A9Mlgt1_YRuaJ_rObN8rE3Tr8Aji6g7Q priority: 102 providerName: ProQuest
Title	Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study
URI	https://www.ncbi.nlm.nih.gov/pubmed/29232366 https://www.proquest.com/docview/1988038190 https://www.proquest.com/docview/1976439687 https://pubmed.ncbi.nlm.nih.gov/PMC5726614 https://doaj.org/article/c0c114d34a874bf2ac360d550a49ab8a http://dx.doi.org/10.1371/journal.pmed.1002468
Volume	14
WOSCitedRecordID	wos000418946400005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: DOA dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: 7X7 dateStart: 20041001 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: BENPR dateStart: 20041001 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: PIMPY dateStart: 20041001 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVATS databaseName: Public Library of Science (PLoS) Journals Open Access customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: FPL dateStart: 20040101 isFulltext: true titleUrlDefault: http://www.plos.org/publications/ providerName: Public Library of Science
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELdYhxAvfMMCoxiE4CmQ2Kmd8NahTkxipRofKk-Rv1IqbUm1trzwz3PnpIFMnRgveYjPkXWXs39nn39HyEsmTREZ68KosAoClBh8LtEqFCzWcSZdnA3qYhNyPE6n02zyJ1C8cILPZfy20embBawOnjA0EekO2WVcCEzhOpx8bAOsLMqi5nrcZT07y49n6W_n4t7itFpuA5oX8yX_WoAOb__v0O-QWw3UpMP637hLrrnyHrlx3Bym3ye_RuDeCFjLGQUYSOsLk7QqKGgbZsIV7jbAQGibjE6rknrCDnrmUTsgeGws7ZLOS-qr8dG68NA7OqRnLSMsfMNX3MGr79QT2j4gXw9HX95_CJtaDKGRIlmFLC0iwEbKOmF1kYEpueaALiwbFEVaOOcGwuhBVKRaCqFYZmGmSGSqY8O104I_JL2yKt0eoYaZJEoSowRzsISmSsfO2sRyjmxrCQsI35goNw1ROdbLOM396ZuEgKVWYI56zRu9BiRsey1qoo5_yB-g9VtZpNn2L8CAeeO1uYkMxIuWJyqViS6YMlxEFoI6lWRKpyogz_Dfyes7q-1kkQ8xuQigquQBeeElkGqjxFyemVovl_nRp29XEPo8vorQSUfodSNUVKAzo5pLFqB55PnqSL7qSM5qlvNtgvsdQZh-TKd5D_1mo-NlHmewJOA-QAQ9N760vfl524wfxWy_0lVrlJEIlEUqA_Kodr3WTgwiEvT9gMiOU3YM2W0p5z88b_pAejT6-PIRPyE3GcK2GAv-7JPe6nztnpLr5udqvjzvkx05lf6Z9snuwWg8Oen7PZy-n4bg3eToePL9NxplhlI
linkProvider	Public Library of Science
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLZGQcALd1hgMIO4PIUlThonSAgV2LRqW0FjoL4F31IqbUlpWhDiP_EbOcdJswVVsJc98Fp_iVL7XO3j7xDymHGVeUob18u0gATFB50LpXAj5ks_4cZPulWzCT4YxMNh8n6F_FrchcGyyoVNtIZaFwr3yDcgOY7xVCvxXk2-utg1Ck9XFy00KrHYMT--Q8pWvuy_hfV9wtjW5sGbbbfuKuAqHoUzl8WZB15eaBNpmSXwUYEMwE9q1s2yODPGdCMlu14WSx5FgiUaZD7ksfRVII2MAnjvOXIe7DjHEjI-PE7wEs_u6SDrmeszzuuregH3N2rJeD4BH2dpT0Mkdz3hCm3HgMYvdCaHRbks6P2zdvOEM9y6-r9N4zVypQ67aa_Sk-tkxeQ3yMW9urDgJvm5CaYOg_d8RCEkptXlUVpkFCQPvMIMd15gImhTmE-LnFryEnpkMxjIZnAw1yUd59R2JqRVE6YXtEePGnZceIftPoQ0ANSS-94iH8_kr98mnbzIzSqhiqnQC0MlImYgnIiF9I3WoQ4CZJ4LmUOChYikqiZtx94hh6k9ieSQvFUTmKJgpbVgOcRtnppUpCX_wL9G6WuwSDlufyimo7S2YKnyFOTOOghFzEOZMaGCyNOQ4IowETIWDllH2U2r-7uN4Ux7WGgFYTsPHPLIIpB2JMe6ppGYl2Xaf_fpFKAPg9OA9lugZzUoK2DOlKgvnMDMI-dZC_m0hRxVjO_LgGstIJhi1RpeRb1dzHGZHmsbPLnQx-XDD5thfClWPuammCOGY9IQxdwhdyrVb9aJQXbGgihyCG8ZhdZCtkfy8RfLId_lNjK_-_fPWieXtg_2dtPd_mDnHrnMMKT1sRnSGunMpnNzn1xQ32bjcvrAGkJKPp-1yfgNhD_xyg
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLZGQRMv3GGBwQzi8hSa2GmcICFU2CqqQZkYoL4Fx3ZKpS0pTQtC_DN-Hec4abagCfayB17rL1F6fHwu9vF3CHnIhMo8pY3rZVpCguLDmgtS6YbMT_1YGD_uVc0mxGgUjcfx3hr5tboLg2WVK5toDbUuFO6RdyE5jvBUK_a6WV0Wsbc9eDH76mIHKTxpXbXTqFRk1_z4Dulb-Xy4DXP9iLHBzodXr926w4CrRBgsXBZlHnh8qU2o0yyGD-QpB5-pWS_LoswY0wtV2vOyKBVhKFmsQf8DEaW-4qlJQw7vPUfOC84Fto0Q46NkL_bs_g4yoLk-E6K-tseF36215OkM_J2lQA2Q6PWYW7TdAxof0ZkdFOVJAfCfdZzHHOPg8v8s0ivkUh2O0361fq6SNZNfI-tv64KD6-TnDphADOrzCYVQmVaXSmmRUdBI8BYL3JEBodCmYJ8WObWkJvTQZjaQ5eBgrks6zantWEir5kzPaJ8eNqy58A7blQjpAagl_b1BPp7JX79JOnmRmw1CFVOBFwRKhsxAmBHJ1DdaB5pzZKQLmEP4Sl0SVZO5Y0-Rg8SeUApI6ioBJqhkSa1kDnGbp2YVmck_8C9RExssUpHbH4r5JKktW6I8BTm15oGMRJBmTCoeehoSXxnEMo2kQ7ZQj5PqXm9jUJM-FmBBOC-4Qx5YBNKR5KiFE7ksy2T47tMpQPuj04Det0BPalBWgMyUrC-igOSRC62FfNxCTiom-JOAmy0gmGjVGt7ANbyScZkcrTx4crU2Tx6-3wzjS7EiMjfFEjECk4kwEg65VZmBZp4YZG2Mh6FDRMtAtCayPZJPv1hu-Z6wEfvtv3_WFlkHS5G8GY5275CLDCNdH3skbZLOYr40d8kF9W0xLef3rE2k5PNZW4zfSY76fg
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Estimating+the+impact+of+antiretroviral+treatment+on+adult+mortality+trends+in+South+Africa%3A+A+mathematical+modelling+study&rft.jtitle=PLoS+medicine&rft.au=Johnson%2C+Leigh+F&rft.au=May%2C+Margaret+T&rft.au=Dorrington%2C+Rob+E&rft.au=Cornell%2C+Morna&rft.date=2017-12-12&rft.pub=Public+Library+of+Science&rft.issn=1549-1277&rft.volume=14&rft.issue=12&rft_id=info:doi/10.1371%2Fjournal.pmed.1002468&rft.externalDBID=IOV&rft.externalDocID=A520932473
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1549-1676&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1549-1676&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1549-1676&client=summon